SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.86 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.86 Cr |
| Mar2024 | ₹0.55 Cr |
| Mar2023 | ₹0.55 Cr |
| Mar2022 | ₹0.55 Cr |
| Mar2017 | ₹2.74 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.86 Cr | 56.18 | |
| Mar2024 | ₹0.55 Cr | 0.00 | |
| Mar2023 | ₹0.55 Cr | 0.00 | |
| Mar2022 | ₹0.55 Cr | -79.96 | |
| Mar2017 | ₹2.74 Cr | - | |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,356.4 Cr | 2% | -6% | -27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2% |
-6% |
-27.1% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses